Helsby, Nuala http://orcid.org/0000-0001-6570-5368
Yong, Minghan http://orcid.org/0000-0002-7853-2651
Burns, Kathryn http://orcid.org/0000-0003-4951-3539
Findlay, Michael http://orcid.org/0000-0002-3305-9768
Porter, David http://orcid.org/0000-0002-3115-8244
Funding for this research was provided by:
Genesis oncology trust
Cancer Society of New Zealand
Article History
Received: 28 February 2021
Accepted: 30 May 2021
First Online: 10 June 2021
Declarations
:
: The authors declare that they have no conflict of interest.
: As noted in the main text this study received approval from the New Zealand Heath and Disability Northern X Regional Ethics committee (NTX/12/06/052). Patients were eligible for the study if they were diagnosed with carcinoma of the breast and scheduled to receive cyclophosphamide treatment. Patients had to be at least 18 years of age and able to give informed written consent. The study was performed in accordance with the Declaration of Helsinki.
: All authors consent to publication.